(Total Views: 970)
Posted On: 07/11/2020 1:42:21 PM
Post# of 30067
Updated information on AVDX
"AMBS - Avant Diagnostics ( 30% )
Theralink®, the proprietary phosphoprotein tumor analysis platform run using reverse phase protein array (RPPA) platform.
CAP/CLIA Lab certified in the future"
This now has changed.
I am unsure what percentage and or new shares AMBS holds of the new entities.
AVDX is now OBMP (OncBioMune) and uses a newly launched website
https://theralink.com
They moved the lab from MD to CO and
"The Company believes that it will be able to obtain the CLIA/CAP certifications in the second or third quarter of 2020, but the New Lab is currently operational."
Per 8K
https://app.quotemedia.com/data/downloadFilin...CK=1362703
"AMBS - Avant Diagnostics ( 30% )
Theralink®, the proprietary phosphoprotein tumor analysis platform run using reverse phase protein array (RPPA) platform.
CAP/CLIA Lab certified in the future"
This now has changed.
I am unsure what percentage and or new shares AMBS holds of the new entities.
AVDX is now OBMP (OncBioMune) and uses a newly launched website
https://theralink.com
They moved the lab from MD to CO and
"The Company believes that it will be able to obtain the CLIA/CAP certifications in the second or third quarter of 2020, but the New Lab is currently operational."
Per 8K
https://app.quotemedia.com/data/downloadFilin...CK=1362703
(2)
(1)
